Developing Chairside Inflammatory-Risk Screening for Dental Care
Medora™ is Biomedisca's flagship investigational point-of-care test under development. It is designed to use a small fingerstick blood sample to provide an inflammatory-risk screening signal during a dental visit, alongside periodontal findings and medical history.
Targeting a binary screening signal in approximately 15 minutes without a separate reader. Finished-product performance requires verification.
Medora is under development, has not been cleared or approved by the U.S. FDA, and is not currently available for clinical use or sale.
From Oral Inflammation to Broader Health Awareness
Periodontal inflammation is usually evaluated and treated within the dental setting, but the inflammatory picture may extend beyond the mouth. Medora is designed to bring rapid inflammatory screening into the same dental visit, helping dental professionals recognize when additional health awareness and medical follow-up may be appropriate.
Identify
The patient presents with signs of periodontal inflammation during a routine dental visit.
Screen
A rapid fingerstick-based Medora test provides inflammatory biomarker information during the same visit.
Connect
The result supports broader health awareness and can help determine when appropriate medical follow-up should be considered.
“The goal is not to diagnose systemic disease in the dental office—it is to identify an inflammatory signal that should not be overlooked.”
Medora is an investigational device under development and has not been cleared by the FDA.
Same-Visit Insight
Rapid screening integrated into the existing dental workflow.
Simple & Chairside
Designed as an easy-to-use binary rapid test without complex instrumentation.
Preventive Approach
Helps move care from reacting to disease toward earlier health awareness.
Dental–Medical Connection
Creates a practical bridge between oral-health findings and appropriate medical follow-up.
Transforming the dental visit into a new frontline for preventive health.
Connecting Oral Health with Broader Preventive Care
Periodontal inflammation and systemic inflammatory burden may coexist, but dental professionals currently lack a practical same-visit tool for evaluating this relationship. Medora is being developed to help close that clinical information gap.
The Intended Chairside Workflow
Fingerstick Sample
A small whole-blood sample is collected from the patient during the visit.
Sample Preparation
The blood sample is prepared with the supplied buffer for testing.
Apply to Medora
The prepared sample is added directly to the Medora test cassette.
Plasma Separation & Flow
The integrated test architecture separates plasma and moves the sample across the detection membrane.
Dual-Signal Detection
Two complementary inflammatory signals are evaluated simultaneously within a single test.
Read the Result
Visible test lines are intended to provide a binary screening signal in approximately 15 minutes without a separate reader. These are development targets.
Concept illustration of the proposed test architecture. Collection, preparation, test-line interpretation, timing, and reader-free use require verification in the finished product.
A Clear Result, Not a Diagnostic Label
Medora's intended output is a binary screening signal. The illustrations below describe the proposed interpretation, which requires validation; they are not patient results or disease-risk grades.
Elevated Inflammatory-Risk Signal Detected
The intended positive output would indicate the target inflammatory signal. It would not identify the source of inflammation or diagnose systemic disease. Any future follow-up would depend on the complete clinical assessment.
No Elevated Inflammatory-Risk Signal Detected
The intended negative output would indicate that the target screening signal was not detected. It would not exclude cardiovascular disease, systemic inflammation, or another medical condition.
Warning: Medora is a screening tool under development. It is not intended to independently diagnose, treat, prevent, or rule out any disease.
How Medora May Fit into Dental Care
Routine dental and periodontal assessment.
Identify a patient who may benefit from additional inflammatory-risk screening.
If validated and authorized, perform Medora testing during the same visit.
Review the binary result alongside medical and dental history.
Provide education and consider appropriate follow-up.
Repeat screening when clinically appropriate after the product is authorized for use.
This is an intended future workflow, subject to validation and applicable authorization. Medora is not currently available for clinical use.
Clinical Value
Medora's intended benefits across dental and medical care require product-specific evaluation.
Dental Providers
- Adds preventive-health capability to the dental visit.
- Supports patient education.
- Creates a more structured medical-referral conversation.
- Provides an objective screening signal.
Medical Providers
- May provide additional oral-health context.
- Supports communication between dental and medical teams.
- May add screening context to a clinician's referral discussion.
- Does not replace conventional cardiovascular evaluation.
Patients
- Small fingerstick sample.
- Same-visit result.
- Clear and understandable screening output.
- Encourages awareness and appropriate follow-up.
Scientific Background & Product Development
Published oral–systemic research provides scientific background. Medora’s performance and clinical usefulness require product-specific validation.
Background Science
Peer-reviewed research describing associations among periodontal inflammation, systemic inflammatory burden, and cardiovascular health.
Background scientific evidenceAssay Development
Medora’s investigational screening methodology is under development. Its performance must be established through product-specific validation.
Development programProspective Product Validation
Product-specific validation is needed to establish analytical performance, fingerstick-to-reference agreement, reliability in dental-office workflows, and clinical usefulness.
Validation requirementsFeatured Peer-Reviewed Publications
Background scientific evidence — these publications describe the oral–systemic research landscape; they are not direct validation of Medora.
Bridging oral and systemic health: exploring pathogenesis, biomarkers, and diagnostic innovations in periodontal disease
Published in Infection — Springer
Periodontal biomarkers in cardiovascular disease: mechanisms, diagnostics, and clinical implications
Published in Infection — Springer
Association between periodontal pathogens and systemic disease
Published in Biomedical Journal
These publications provide scientific background and are not product validation. Explore the Science & Development page for development requirements, or browse Publications.
Product Development Roadmap
FDA review has not begun.
Prototype development
Analytical verification
Prospective clinical validation
Regulatory submission
Point-of-care authorization
Commercial introduction
Regulatory submission, point-of-care authorization, and commercial introduction depend on prospective study outcomes and applicable regulatory review.
Interested in Evaluating Medora?
We welcome clinical research collaborations, strategic partnerships, and investor inquiries.
Continue Exploring
Explore the product details, scientific context, and next steps that matter to you.